ArticleHuman heredity2026
Comparative Profiles of Pediatric Mendeliome: A Single-Center 572-Whole-Exome Sequencing Study in Xinjiang.
Article in Human heredity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionThe aim of the study was to compare the diagnostic yields and utility of whole-exome sequencing (WES) for Mendelian disorders in pediatric patients of different ethnic backgrounds in Xinjiang.
methodsA retrospective analysis of 572 pediatric patients suspected of Mendelian disorders, admitted to the Pediatric Center of the First Affiliated Hospital of Xinjiang Medical University from January 2016 to June 2020. WES was performed in accredited laboratories, and reports were verified by supervising physicians.
resultsThe overall diagnostic yield was 42.3%, with a higher yield in Uyghur than Han patients (46.5% vs. 36.2%). Inheritance pattern distributions differed by ethnicity: autosomal recessive findings were more frequent in Uyghur (60.8%) than Han (29.8%), whereas autosomal dominant (46.4%) and de novo variants (38.1%) comprised larger proportions in Han than in Uyghur (31.6% and 22.8%); X-linked findings were less common in both groups. Diagnostic yield varied by phenotype category (33.3%-73.1%), was generally higher in consanguineous than non-consanguineous cases, and increased with phenotypic complexity (16.7%, 54.1%, and 85.7% across increasing phenotype burden). Among patients with follow-up, WES results influenced medication management (61.0%), clinical/dietary management (89.2%), and subspecialist referral (36.9%).
conclusionExome testing shows higher diagnostic yield and clinical utility, especially for patients from consanguineous families in Xinjiang. Carrier screening could effectively prevent severe genetic disorders in the region, expanding the genotype and phenotype in the Chinese pediatric population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.